Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.23.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]      
Revenues $ 810 $ 853 $ 763
Research and development expenses (7,763) (9,850) (11,951)
General and administrative expenses (3,143) (3,845) (2,951)
Operating loss (10,096) (12,842) (14,139)
Total financial income (expense), net (77) 227 (304)
Loss before taxes on income (10,173) (12,615) (14,443)
Taxes on income
Net loss (10,173) (12,615) (14,443)
Deemed dividend (2,590) (715)
Total comprehensive loss $ (10,173) $ (15,205) $ (15,158)
Basic and diluted net loss per share (in Dollars per share) $ (0.01) $ (0.03) $ (0.04)
Weighted average number of ordinary shares used in computing basic and diluted net loss per share (in Shares) 815,746,293 553,079,638 358,411,297